How Humana, Blue Shield of CA, and Noom Are Reimagining GLP-1 Integration and Obesity Care
Host Eric Glazer convenes senior leaders from Humana, Noom, and Blue Shield of California to explore how payers are integrating GLP-1 therapies into comprehensive cardio-metabolic care strategies. The conversation outlines how digital, behavioral, and clinical interventions can align to deliver sustainable outcomes, lower costs, and strengthen member engagement.
Panelists share real-world playbooks on scaling GLP-1 programs responsibly—balancing access, affordability, and long-term adherence through consumer-centric design and data-driven clinical support.
What You’ll Learn
- How Humana’s CenterWell Pharmacy is transforming outcomes through AI-enabled automation, disease-specific Centers of Excellence, and a high-touch consumer experience.
- How Noom and forward-thinking health plans are using trust as currency to deepen engagement and sustain lifestyle change.
- How Blue Shield of California is implementing a step-therapy model that balances GLP-1 access with lifestyle interventions and clinical oversight.
- Why integration across benefit design, behavior change, and pharmacology is redefining obesity management.
- What future models look like for holistic, clinician-guided weight management and cardiometabolic care.
Quotable Moments
- “Trust isn’t optional—it’s the currency that earns you the right to guide someone through change.” – Cody Fair, Chief Commercial Officer, Noom
- “You can have efficiency and still be high-touch. AI and automation don’t replace pharmacists—they empower them.” – Bethany Stein, President of Pharmacy, Humana
- “GLP-1s are a tool, not the strategy. Success means combining medication with behavioral, nutritional, and clinical support.” – Angie Okaloosa-Ibrahimi, Senior Director, Lifestyle Medicine, Blue Shield of California
- “Culture—caring, curious, and committed—is the foundation of transformation.” – Bethany Stein, Humana
Timestamped Hooks
- 00:08:00 – 00:09:00: Eric introduces the GLP-1 integration playbook and the challenge of turning high-cost therapies into sustainable value.
- 00:12:30 – 00:14:00: Humana’s digital transformation: from internal pharmacy to 95% retention and NPS of 87.
- 00:15:20 – 00:17:40: Noom on building trust through “Your Ultimate Why.”
- 00:20:00 – 00:25:00: Blue Shield of California on managing GLP-1 demand and step-therapy protocols.
- 00:31:00 – 00:33:00: Noom’s opt-out model driving 90% employer participation.
- 00:44:00 – 00:47:00: Humana partners with pharma to deliver GLP-1s at up to 70% lower cash prices.
- 00:55:00 – 00:57:00: “Caring, Curious, and Committed” – the cultural foundation for consumer-centric care.
- 01:03:30 – 01:04:50: Blue Shield on building Netflix-style personalization for obesity and MSK programs.
Discussion Highlights
- Integrating GLP-1 therapies within holistic benefit design frameworks.
- Leveraging AI and automation in pharmacy operations to enhance adherence and experience.
- The role of behavior-based engagement models in long-term weight management.
- Data-driven approaches to affordability, utilization, and trust-based engagement.
- Creating digital ecosystems that mirror personalized consumer experiences in other industries.
Resources Mentioned
- The GLP-1 Integration Playbook (Noom, 2025)
- Evolution program, Blue Shield of California
- CenterWell Pharmacy patient experience data
Bright Spots Ventures- Partner Acknowledgment
Special thanks to Noom for supporting this episode. Noom combines behavioral science, technology, and clinical guidance to deliver measurable results in metabolic health. Learn more at noom.com/health.
